共 50 条
- [21] PREDICTORS OF EPIDERMAL GROWTH FACTOR (EGFR) TESTING AMONG PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (MNSCLC) TREATED IN THE REAL-WORLD SETTINGVALUE IN HEALTH, 2023, 26 (06) : S218 - S218Vasudevan, A.Sura, T.English, S.Wang, B.Varughese, P.Katzen, H.
- [22] Impact of clinical pathways on treatment patterns and outcomes for patients with non-small-cell lung cancer: real-world evidence from a community oncology practiceJOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (08) : 609 - 619Dickson, Natalie R.Beauchamp, Karen D.Perry, Toni S.Roush, AshleyGoldschmidt, DeborahEdwards, Marie LouiseBlakely, Laura J.
- [23] Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung CancerCANCERS, 2022, 14 (18)Danesi, ValentinaMassa, IlariaFoca, FlaviaDelmonte, AngeloCrino, LucioBronte, GiuseppeRagonesi, MariaMaltoni, RobertaManunta, SilviaCravero, PaolaAndrikou, KalliopiPriano, IlariaBalzi, WilliamGentili, NicolaBurke, ThomasAltini, Mattia
- [24] Real-world treatment outcomes with brigatinib in patients with pretreated ALK plus metastatic non-small cell lung cancerLUNG CANCER, 2021, 157 : 9 - 16Popat, SanjayBrustugun, Odd TerjeCadranel, JacquesFelip, EnriquetaGarassino, Marina ChiaraGriesinger, FrankHelland, AslaugHochmair, MaximilianPerol, MauriceBent-Ennakhil, NawalKruhl, ChristianNovello, Silvia
- [25] Testing patterns and outcomes of different EGFR-positive metastatic non-small cell lung cancer (NSCLC) patients in a Canadian real-world settingANNALS OF ONCOLOGY, 2022, 33 : S56 - S56Boyne, D. J.Jarada, T.Yusuf, A.O'Sullivan, D. E.Hu, L. X. Y.Brenner, D. R.Abbie, E.Rose, J. B.Eaton, K.Ewara, E. M.Cheung, W. Y.
- [26] Real World Outcomes after Chemotherapy and Immunotherapy in Patients with Metastatic Non-Small Cell Lung Cancer in EuropeJOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S632 - S632Leal, T.Dasgupta, A.Latremouille-Viau, D.Yang, M.Hu, X.Liu, S.Barlesi, F.
- [27] Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancerLUNG CANCER, 2022, 165 : 115 - 123Wu, JunqiHou, LikunZhao, YueYu, XinXu, LongNing, YeDeng, JiajunSun, KeZhang, JieWu, ChunyanZhu, YumingZhao, DepingShe, YunlangSu, ChunxiaChen, ChangHaoran, E.
- [28] Retrospective Analysis of Real-World Treatment Patterns and Survival Outcomes for Non-small Cell Lung Cancer Patients in ThailandJOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S603 - S604Supaattagorn, S.Maneenil, K.
- [29] Evaluating the potential of immunotherapy and chemoimmunotherapy in the treatment of elderly non-small cell lung cancer patients: A real-world studyCANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 37Endo, SatoshiHonda, TakayukiSato, KazuakiKubota, NatsushiKamoshida, TatsuhikoMochizuki, AkifumiFujii, MayumiOchi, JunichiMiyazaki, YasunariTsukada, Yoshikazu
- [30] Patient characteristics, treatment patterns, and clinical outcomes among patients with de novo advanced or metastatic (stage IIIB-IV) non-small cell lung cancer in a real-world settingJOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Yang, MoMacEwan, Joanna P.Boppudi, Sai SritejaMcClain, MonicaO'Hara, RichardPaik, Paul K.